On January 31, 2022, Ronald W. Barrett, Independent Director notified Concert Pharmaceuticals, Inc. that he will not stand for re-election at the company's 2022 Annual Meeting of Stockholders. Dr. Barrett's decision to not stand for re-election was personal and not related to any disagreement with the company on any matter relating to its operations, policies or practices.
Concert Pharmaceuticals, Inc.
Equities
CNCE
US2060221056
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+43.36% | 58.06B | |
-5.31% | 40.53B | |
+37.52% | 38.99B | |
+14.75% | 26.7B | |
-12.56% | 26.56B | |
-22.45% | 18.98B | |
+0.04% | 12.17B | |
+25.12% | 12B | |
+26.04% | 11.92B |